Lv1
20 积分 2025-08-18 加入
Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates diabetic nephropathy via suppressing SLC7A11-mediated ferroptosis
1天前
待确认
Finerenone prevents renal damage by enhancing SDF-1α/CXCR4-mediated stem cell mobilization in experimental type 1 diabetic nephropathy
1天前
已完结
Autosomal Dominant Polycystic Kidney Disease
9天前
已完结
Finerenone in Chronic Kidney Disease: A Comprehensive Review of Mechanisms, Efficacy and Safety
16天前
已完结
Antagonistic effects of finerenone and spironolactone on the aldosterone‐regulated transcriptome of human kidney cells
16天前
已完结
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
21天前
已完结
Discovery of BAY 94‐8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases
21天前
已完结
Genome-wide analysis of murine renal distal convoluted tubular cells for the target genes of mineralocorticoid receptor
29天前
已完结
Autosomal Dominant Polycystic Kidney Disease
1个月前
已完结
Tissue-specific expression and regulation of the mineralocorticoid receptor during development
1个月前
已关闭
皖公网安备34019202002308
